Bruker price target lowered to $90 from $95 at BofA

BofA lowered the firm’s price target on Bruker to $90 from $95 and keeps a Buy rating on the shares after the company hosted a modeling update call following a series of recent M&A activity and updated their mid-term outlook. While the webinar did provide some clarity on out-years, there’s still some uncertainty on 2025, says the firm, updated its model and revised its estimates following the event.